Amundi Has $49.15 Million Stake in Docusign Inc. $DOCU

Amundi boosted its position in Docusign Inc. (NASDAQ:DOCU - Free Report) by 19.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,036,657 shares of the company's stock after buying an additional 170,299 shares during the quarter. Amundi owned approximately 0.53% of Docusign worth $49,148,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the stock. Modus Advisors LLC acquired a new position in shares of Docusign in the 4th quarter worth approximately $27,000. Torren Management LLC acquired a new position in shares of Docusign during the fourth quarter worth approximately $28,000. Cary Street Partners Investment Advisory LLC lifted its position in shares of Docusign by 309.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 561 shares of the company's stock worth $38,000 after purchasing an additional 424 shares in the last quarter. Basepoint Wealth LLC bought a new stake in shares of Docusign during the fourth quarter valued at approximately $39,000. Finally, WealthCollab LLC grew its stake in shares of Docusign by 372.4% during the first quarter. WealthCollab LLC now owns 855 shares of the company's stock valued at $41,000 after purchasing an additional 674 shares during the last quarter. Institutional investors own 77.64% of the company's stock.

Insider Activity at Docusign

In related news, insider Robert Chatwani sold 15,902 shares of the business's stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $43.01, for a total value of $683,945.02. Following the completion of the sale, the insider directly owned 72,805 shares in the company, valued at $3,131,343.05. The trade was a 17.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Allan C. Thygesen sold 26,250 shares of the company's stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $46.02, for a total value of $1,208,025.00. Following the completion of the transaction, the chief executive officer directly owned 159,038 shares in the company, valued at approximately $7,318,928.76. This represents a 14.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 76,695 shares of company stock valued at $3,476,002 in the last 90 days. Corporate insiders own 0.59% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on DOCU. UBS Group set a $60.00 target price on shares of Docusign in a research note on Friday, June 5th. BTIG Research cut their price objective on shares of Docusign from $70.00 to $60.00 and set a "buy" rating on the stock in a report on Friday, June 5th. Jefferies Financial Group raised their price objective on shares of Docusign from $45.00 to $50.00 and gave the company a "hold" rating in a research note on Friday, June 5th. Wall Street Zen downgraded Docusign from a "strong-buy" rating to a "buy" rating in a research note on Sunday. Finally, Wells Fargo & Company lowered their price target on shares of Docusign from $60.00 to $55.00 and set an "equal weight" rating on the stock in a research note on Friday, June 5th. Three analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $60.27.

Docusign Stock Performance

DOCU opened at $54.83 on Monday. The stock's fifty day simple moving average is $48.42 and its 200 day simple moving average is $48.32. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $86.65. The stock has a market cap of $10.47 billion, a PE ratio of 35.60, a price-to-earnings-growth ratio of 1.62 and a beta of 0.90.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping the consensus estimate of $0.99 by $0.10. Docusign had a net margin of 9.59% and a return on equity of 17.48%. The business had revenue of $830.24 million during the quarter, compared to the consensus estimate of $824.71 million. During the same quarter in the previous year, the firm posted $0.90 EPS. Docusign's revenue was up 8.7% compared to the same quarter last year. Equities analysts forecast that Docusign Inc. will post 2.03 earnings per share for the current year.

Docusign Company Profile

DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.